Immunoenzymatic assay of insulin-like growth factor binding protein-3
β Scribed by A. Diamandi; M.J. Khosravi; J. Mistry; G. Mathew
- Publisher
- Elsevier Science
- Year
- 1995
- Tongue
- English
- Weight
- 118 KB
- Volume
- 28
- Category
- Article
- ISSN
- 0009-9120
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Insulin-like growth factors (IGFs) are potent mitogens involved in the regulation of cell proliferation and apoptosis. The action of IGFs is mediated through a specific cell membrane receptor (IGF-IR), and the interactions between IGFs and this receptor are regulated by IGF-binding proteins (IGFBPs)
## Abstract Recent epidemiological studies have shown that high serum levels of insulinβlike growth factorβI (IGFβI) are associated with an increased risk of lung, colon, breast and prostate cancer. Since very few studies have addressed the role of serum levels of IGFβI in the development of pancre
The mitogenic effects of insulin-like growth factors (IGFs) are regulated by a family of insulin-like growth factor binding proteins (IGFBPs). One member of this family, IGFBP-3, mediates the growth-inhibitory and apoptosis-inducing effects of a number of growth factors and hormones such as transfor
Previously we have shown that transforming growth factor b (TGF b) 1, basic fibroblast growth factor (FGF), and platelet-derived growth factor (PDGF) BB inhibit the synthesis of insulin-like growth factor (IGF) II, but their effects on IGF binding protein (IGFBP)-6 in osteoblast cultures are not kno